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     Medicinal plants and lactic acid bacteria are used to treat a wide range of disease 
conditions. The aim of the study was to determine antimicrobial and antioxidant 
activities of bioactive compounds and peptides from different morphological parts of 
common medicinal plants namely Morinda citrifolia, Annona squamosa, Alstonia 
angustiloba, an Australian plant mixture and lactic acid bacteria. In the first part of the 
study, different methods were used to standardize the extraction of antimicrobial and 
antioxidant compounds. It was found that methanol extraction of plants tissue showed 
higher antimicrobial activity than aqueous extracts against the test bacteria 
Staphylococcus aureus (RF 122), Escherichia coli (UT181), Bacillus cereus (ATCC 
14579), Pseudomonas aeruginosa (PA7), methicillin-resistant Staphylococcus aureus 
(ATCC BA-43) and Helicobacter pylori (ATCC 43504). Furthermore, plant tissues 
showed significant antioxidant activities using DPPH and SOD assays. GC-MS analysis 
of extracts revealed bioactive compounds (diterpenes, anthraquinones, alkaloids, 
organic acids) in these extracts.   
 
     In the second part of the study, bioactive compounds were fractionated into 
anthroquinones, alkaloids, diterpenes and phenolic compounds. Anthraquinones extracts 
from the fruit, leaf and root of M. citrifolia exhibited significant antibacterial activity 
against all strain of test bacteria. Anthraquinones extracted from the fruit have higher 
level of antioxidant activities compared to another parts of the plant. IR spectra of the 
anthraquinones extracts of M. citrifolia indicated the presence of O-H, C=O, C-H 
groups. A significant morphological change in cell wall, membrane and destruction of 




     Alkaloid extracts from the medicinal plants showed antibacterial activity against 
pathogenic bacteria including MRSA and H. pylori while P. aeruginosa was resistant to 
alkaloids extracted from M. citrifolia fruit. Alkaloid extracts from A. squamosa leaves 
have a high level of antioxidant activities. IR spectra of the alkaloid extracts indicated 
the presence of O-H, C=O, C-H and N-H groups. SEM observations of the action of 
alkaloids on bacterial cell wall showed rupture and cell lysis.  
 
     Phenolic compounds extract from plant mixture gave antibacterial and antioxidant 
activities. Diterpens extracts from A. squamosa fruit had significant antibacterial 
activity against pathogenic bacteria and MRSA and significant antioxidant activity. 
SEM observation of the action on bacterial cells showed disruption of cell wall and 
swelling of the cells. IR spectra of diterpenes and phenolic compounds indicated the 
presence of O-H, C-H, C=O and C-H groups. LC-MS analysis of bioactive compounds 
plants identified specific compounds.   
 
     In the third part of the study, antibacterial peptides extracted from lactic acid bacteria 
by the acidic methanolic method were shown to have activity against pathogenic 
bacteria including MRSA and H. pylori and had antioxidant activity. LC-MS analysis of 
peptide of Lactobacillus paracasei subsp. paracasei 8700:2 identified a novel 
bacteriocin in this extract. 
 
     Peptides extracts from the medicinal plants had significant antibacterial and 
antioxidant activities. LC-MS analysis of Australian plant mixture indicated the 
presence of Pathogenesis-related protein 2 of Phaseolus vulgaris. SEM and TEM 
analysis of the mechanism of action of purified peptides from lactic acid bacteria and 







     Tumbuhan ubatan dan bakteria asid laktik digunakan untuk merawat pelbagai 
penyakit. Tujuan kajian ialah untuk menentukan aktiviti agen antimikrob dan 
antioksidan sebatian bioaktif dan peptida dari bahagian-bahagian morologikal berbeza 
tumbuhan ubatan  (Morinda citrifolia, Annona squamosa, Alstonia angustiloba dan 
tumbuhan Australia campuran) dan bakteria asid laktik. Dibahagian pertama kajian, 
pelbagai kaedah digunakan untuk menstandardkan pengekstrakan sebatian agen 
antimikrob dan antioksidan. Di dapati pengekstrakan metanol tisu tumbuh-tumbuhan 
menunjukkan aktiviti antimikrob lebih tinggi daripada ekstrak akueus terhadap bakteria 
ujian, Staphylococcus aureus (RF 122), Escherichia coli (UT181), Bacillus cereus 
(ATCC 14579), Pseudomonas aeruginosa (PA7), Staphylococcus aureus tahan 
methicillin (ATCC BA-43) dan Helicobacter pylori (ATCC 43504). Tambahan pula, 
tisu tumbuh-tumbuhan menunjukkan aktiviti penting antioksidan dengan menggunakan 
ujian DPPH and SOD. Analisis merggunttan GC-MS ekstrak mendedahkan sebatian 
bioaktif (diterpena, anthraquinones, alkaloid, asid organik) dalam ekstrak ini. 
     Dibahagian kedua kajian, sebatian bioaktif diasingkan  kepada anthroquinones, 
alkaloid, diterpena dan sebatian fenol. Anthraquinones dari buah, daun dan akar M. 
citrifolia menunjukkan aktiviti antibakteria yang mynrbtan terhadap semua bakteria 
ujian. Anthraquinones dari buah mempunyai aktiviti-aktiviti antipengoksidan lebih 
tinggi berbanding dengan bahagian-bahagian  lain tumbuhan. Spektrum IR ekstrak 
anthraquinones M. citrifolia menunjukkan kehadiran kumpulan-kumpulan O-H, C=O, 
C-H. Satu perubahan morfologi penting di dinding sel, membran dan kemusnahan sel 
bakteria B. cereus telah diperhatikan seuase  kehadiran anthraquinones. 
     Alkaloid dari tumbuhan ubatan menunjukkan aktiviti antibakteria terhadap bakteria 
patogen termasuk MRSA and H. pylori manakala P. aeruginosa resistan kepada 
 v 
 
alkaloid dari M. citrifolia. Alkaloid dari daun-daun A. squamosa mempunyai peringkat 
tinggi aktiviti-aktiviti antipengoksida. Spektrum IR ekstrak alkaloid menunjukkan 
kehadiran kumpulan-kumpulan O-H, C=O, C-H dan N-H. Pemerhatian-pemerhatian 
SEM menunjukan tindakan alkaloid pada dinding sel bakteria menunjukkan kepecahan 
dan lisis.  
     Sebatian fenolik  dari campuran tumbuhan menunjukan aktiviti antibakteria dan 
antioksidan. Diterpena dari  buah A. squamosa mempunyai aktiviti penting antibakteria 
terhadap bakteria patogen dan MRSA dan  kegiatan antioksidan yay fignrttan. 
Pemerhatian SEM menunjukkan gangguan dinding sel bakteria dan pembengkakan sel. 
Spektrum IR diterpena dan sebatian fenol menunjukkan kehadiran O-H, C-H, 
C=Kumpulan-kumpulan O and C H. Analisis LC-MS  sebatian bioaktif  telah mengenal 
pasti sebatian-sebatian khusus dalam ekstrak.  
     Dibahagian ketiga kajian, peptida antibakteria dari bakteria asid laktik, diasingkan 
dengan kaedah methanolik berasid, menunjukkan keattifan terhadap bakteria patogen 
termasuk MRSA and H. pylori dan mempunyai activiti antioksidan. Analisis LC-MS 
peptida Lactobacillus paracasei subsp. paracasei 8700:2 mengenal pasti satu 
bakteriosin novel dalam ekstrak ini. 
     Ekstrak peptida dari tumbuhan ubatan mempunyai aktiviti antibakteria penting dan 
aktiviti-aktiviti antipengoksida. Analisis LC-MS tumbuhan Australia campuran 
menunjukkan kehadiran protein berkaitan  dengan Pathogenesis 2 Phaseolus vulgaris. 
Analisis SEM and TEM menunjukkan mekanisme tindakan peptida tulen dari bakteria 
asid laktik dan APM menunjukkan gangguan membran bakteria dengan formasi seperti 
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